Analysis of common transforming growth factor beta-1 gene polymorphisms in gastric and duodenal ulcer disease: Pilot study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 4, 2007, Pages 555-564

  Polonikov, Alexey V ^a   Ivanov, Vladimir P ^a   Belugin, Dmitry A ^b   Khoroshaya, Irina V ^a   Kolchanova, Inessa O ^a   Solodilova, Mariya A ^a   Tutochkina, Margarita P ^c   Stepchenko, Alexander A ^a  

^a KURSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^b KURSK STATE UNIVERSITY   (Russian Federation)

^c Kursk Regional Clinical Hospital   (Russian Federation)

Author keywords

Case control study; Gastric and duodenal ulcer disease; Genetic polymorphism; Transforming growth factor beta 1; Ulcer healing

Indexed keywords

ARGININE; LEUCINE; PROLINE; SIGNAL PEPTIDE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD SAMPLING; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DUODENUM ULCER; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PATHOGENESIS; PEPTIC ULCER; PILOT STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RUSSIAN FEDERATION; STATISTICAL ANALYSIS; STOMACH ULCER;

EID: 33947285615     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04542.x     Document Type: Article

References (46)

1. O'Connor HJ. The role of Helicobacter pylori in peptic ulcer disease. Scand. J. Gastroenterol. 1994; 29 (Suppl. 201): 11.
2. Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J. Clin. Gastroenterol. 1997; 24: 2-17.
3. Sumii K, Uemura N, Inbe A et al. Serum pepsinogen 1, gastrin, ABO blood groups, secretor status of ABH substances and behavioral factors in patients with duodenal ulcer and their relatives. Jpn J. Med. 1988; 27: 291-4.
4. Lam SK. Epidemiology and genetics of peptic ulcer. Gastroenterol. Jpn 1993; 28 (Suppl. 5): 145-57.
5. Ohtaki Y, Azuma T, Konishi J, Ito S, Kuriyama M et al. Association between genetic polymorphism of the pepsinogen C gene and gastric body ulcer: the genetic predisposition is not associated with Helicobacter pylori infection. Gut 1997; 41: 469-74.
6. Hein HO, Suadicani P, Gyntelberg F. Genetic markers for peptic ulcer. A study of 3387 men aged 54 to 74 years: the Copenhagen Male Study. Scand. J. Gastroenterol. 1997; 16: 323.
7. Garcia-Gonzalez MA, Lanas A, Santolaria S, Crusius JBA, Serrano MT, Pena AS. The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer. Clin. Exp. Immunol. 2001; 125: 368-75.
8. Lanas A, Garcia-Gonzalez MA, Santolaria S et al. TNF and LTA gene polymorphisms reveal risk in gastric and duodenal ulcer patients. Genes Immun. 2001; 2: 415-21.
9. Morre S, Murillo L, Crusius JB. Relevance of the IL1B-511 and IL-1RN gene polymorphisms and their genotypes in peptic ulcer disease (PUD) and non-ulcer-dyspepsia (NUD) versus Helicobacter pylori cagA subtype infection. Gastroenterology 2002; 122: A-209.
10. Garcia-Gonzalez MA, Lanas A, Savelkoul PH et al. Association of interleukin 1 gene family polymorphisms with duodenal ulcer disease. Clin. Exp. Immunol. 2003; 134: 525-31.
11. Davenport HW. Physiology of the digestive tract. Yearbook. Chicago: Year Book Medical Publication, 1982; 140-1.
12. Jones MK, Tomikawa M, Mohajer B, Tarnawski AS. Gastrointestinal mucosal regeneration: role of growth factors. Front. Biosci. 1999; 15: 303-9.
13. Roberts AM, Sporn MB. Transforming growth factor β. Adv. Cancer Res. 1988; 51: 107-45.
14. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N. Engl. J. Med. 2000; 342: 1350-8.
15. Alison MR, Chinery R, Poulsom R, Ashwood P, Longcroft JM, Wright NA. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor mRNAs in rat stomach. J. Pathol. 1995; 175: 405-14.
16. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 2000; 192: 295-302.
17. Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 2001; 194: 629-44.
18. 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-TEe Cyrillic signmoin de L'Infarctus du Myocarde (ECTIM) study. Hypertension 1996; 28: 881-7.
19. Syrris P, Carter ND, Metcalfe JC et al. Transforming growth factor-β1 gene polymorphisms and coronary artery disease. Clin. Sci. 1998; 95: 659-67.
20. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene: association with TGF-β1 production, fibrotic lung disease and graft fibrosis after lung transplantation. Transplantation 1998; 66: 1014-20.
21. Suthanthiran M, Li B, Song JO et al. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc. Natl. Acad. Sci. USA 2000; 97: 3479-84.
22. Crilly A, Hamilton J, Clark CJ, Jardine A, Madhok R. Analysis of transforming growth factor β1 gene polymorphisms in patients with systemic sclerosis. Ann. Rheum. Dis. 2002; 61: 678-81.
23. Silverman ES, Palmer LJ, Subramaniam V et al. Transforming growth factor-β1 promoter polymorphism C?509T is associated with asthma. Am. J. Respir. Crit. Care Med. 2004; 169: 214-19.
24. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. New York: Cold Spring Harbor Laboratory Press, 1989.
25. Grainger DJ, Heathcote K, Chiano M et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum. Mol. Genet. 1999; 8: 93-7.
26. Lario S, Icigo P, Campistol JM, Poch E, Rivera F, Oppenheimer F. Restriction enzyme-based method for transforming growth factor-β1 genotyping. nonisotopic detection of polymorphisms in codons 10 and 25 and the 5′-flanking region. Clin. Chem. 1999; 45: 1290-2.
27. Pokorny V, Chau J, Wu L et al. Transforming growth factor β1 gene (HSTGFB1) nucleotide T869C (codon 10) polymorphism is not associated with prevalence or severity of rheumatoid arthritis in a Caucasian. Ann. Rheum. Dis. 2003; 62: 907-8.
28. Araria-Goumidi L, Lambert JC, Mann DM et al. Association study of three polymorphisms of TGF-β1 gene with Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2002; 73: 62-4.
29. Wu L, Chau J, Young RP et al. Transforming growth factor-β1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax 2004; 59: 126-9.
30. Zhao H, Pfeiffer R, Gail MH. Haplotype analysis in population genetics and association studies. Pharmacogenomics 2003; 4: 171-8.
31. Liu PY, Zhang YY, Lu Y et al. A survey of haplotype variants at several disease candidate genes: the importance of rare variants for complex diseases. J. Med. Genet. 2005; 42: 221-7.
32. Stromberg E, Edebo A, Svennerholm A-M, Lindholm C. Decreased epithelial cytokine responses in the duodenal mucosa of Helicobacter pylori-infected duodenal ulcer patients. Clin. Diagn. Lab. Immunol. 2003; 10: 116-24.
33. Dignass AU, Podolsky DK. Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor-β. Gastroenterology 1993; 105: 1323-32.
34. Alexandrow MG, Moses HL. Transforming growth factor β and cell cycle regulation. Cancer Res. 1995; 55: 1452-7.
35. Sanderson N, Factor V, Nagy P et al. Hepatic expression of mature transforming growth factor-β1 in transgenic mice results in multiple tissue lesions. Proc. Natl. Acad. Sci. USA 1995; 92: 2572-6.
36. Tarnawski A, Arakawa T, Kobayashi K. Cellular and molecular mechanisms of gastric erosions and ulcer healing. In: Cheil R, Iaquinto G, Szabo S, eds. Gastroduodenal Mucosal Damage: Problems of Protection and Healing. 1997; 155-164.
37. Valverius EM, Walker-Jones D, Bates SE et al. Production of and responsiveness to transforming growth factor-β in normal and oncogene-transformed human mammary epithelial cells. Cancer Res. 1989; 49: 6269-74.
38. Tarnawski A, Santos AM, Ichikawa Y, Lu S-Y, Sarfeh IJ. Antacid talcid stimulates angiogenesis in injured gastric mucosa: a new mechanism for its mucosal healing action. Eur. J. Gastroenterol. Hepatol. 1993; 5: 125-32.
39. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 1998; 16: 137-61.
40. Tzaregorodtzeva TM, Serova TI. Cytokines in Gastroenterology. Moscow: Anakharsis, 2003.
41. Borderie D, Hilliquin P, Hernvann A et al. Inhibition of inducible NO synthase by TH2 cytokines and TGF beta in rheumatoid arthritic synoviocytes: effects on nitrosothiol production. Nitric Oxide 2002; 6: 271-82.
42. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 1994; 10: 1286-92.
43. Ernst H, Konturek PC, Brzozowski T, Konturek SJ, Hahn EG. Subserosal application of transforming growth factor-beta 1 in rats with chronic gastric ulcers: effect on gastric ulcer healing and blood flow. J. Physiol. Pharmacol. 1996; 47: 443-54.
44. Massagne J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 1990; 6: 597-641.
45. Eickelberg O, Kohler E, Reichenberger F et al. Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. Am. J. Physiol. 1999; 276: 814-24.
46. Kucich U, Rosenbloom JC, Abrams WR et al. Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta and p38. Am. J. Respir. Cell Mol. Biol. 2002; 26: 183-8.